{"id":"https://openalex.org/W7225335218","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0679","title":"679 Novel 4-thiazolidinone derivative Les-4367 synergizes with trastuzumab and pertuzumab to suppress immune evasion markers in HER2-positive gastric cancer","display_name":"679 Novel 4-thiazolidinone derivative Les-4367 synergizes with trastuzumab and pertuzumab to suppress immune evasion markers in HER2-positive gastric cancer","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225335218","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0679"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0679","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0679","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0679","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A769.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A769.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037505099","display_name":"Anna Bielawska","orcid":"https://orcid.org/0000-0001-9164-8440","observed_orcids":["https://orcid.org/0000-0001-9164-8440"]},"institutions":[{"id":"https://openalex.org/I146122375","display_name":"Medical University of Bia\u0142ystok","ror":"https://ror.org/00y4ya841","country_code":"PL","type":"education","lineage":["https://openalex.org/I146122375"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Anna Bielawska","raw_affiliation_strings":["Medical University of Bialystok, Bialystok, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Bialystok, Bialystok, Poland","institution_ids":["https://openalex.org/I146122375"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042062147","display_name":"Agnieszka Gornowicz","orcid":"https://orcid.org/0000-0002-0945-7870","observed_orcids":["https://orcid.org/0000-0002-0945-7870"]},"institutions":[{"id":"https://openalex.org/I146122375","display_name":"Medical University of Bia\u0142ystok","ror":"https://ror.org/00y4ya841","country_code":"PL","type":"education","lineage":["https://openalex.org/I146122375"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Agnieszka Gornowicz","raw_affiliation_strings":["Medical University of Bialystok, Bialystok, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Bialystok, Bialystok, Poland","institution_ids":["https://openalex.org/I146122375"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087358193","display_name":"Magdalena Podolak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146122375","display_name":"Medical University of Bia\u0142ystok","ror":"https://ror.org/00y4ya841","country_code":"PL","type":"education","lineage":["https://openalex.org/I146122375"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Magdalena Podolak","raw_affiliation_strings":["Medical University of Bialystok, Bialystok, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Bialystok, Bialystok, Poland","institution_ids":["https://openalex.org/I146122375"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101871337","display_name":"Wojciech Szymanowski","orcid":"https://orcid.org/0000-0002-4760-4253","observed_orcids":["https://orcid.org/0000-0002-4760-4253"]},"institutions":[{"id":"https://openalex.org/I146122375","display_name":"Medical University of Bia\u0142ystok","ror":"https://ror.org/00y4ya841","country_code":"PL","type":"education","lineage":["https://openalex.org/I146122375"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Wojciech Szymanowski","raw_affiliation_strings":["Medical University of Bialystok, Bialystok, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Bialystok, Bialystok, Poland","institution_ids":["https://openalex.org/I146122375"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5124916923","display_name":"Roman Lesyk","orcid":"https://orcid.org/0000-0002-3322-0080","observed_orcids":["https://orcid.org/0000-0002-3322-0080"]},"institutions":[{"id":"https://openalex.org/I24402780","display_name":"Danylo Halytsky Lviv National Medical University","ror":"https://ror.org/0027cag10","country_code":"UA","type":"education","lineage":["https://openalex.org/I24402780"]}],"countries":["UA"],"is_corresponding":false,"raw_author_name":"Roman Lesyk","raw_affiliation_strings":["Danylo Halytsky Lviv National Medical University, Lviv, Ukraine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Danylo Halytsky Lviv National Medical University, Lviv, Ukraine","institution_ids":["https://openalex.org/I24402780"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A769","last_page":"A769"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.7807999849319458,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.7807999849319458,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.19429999589920044,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/4-thiazolidinone-derivatives","display_name":"4-thiazolidinone derivatives","score":0.9259999990463257},{"id":"https://openalex.org/keywords/her2-positive-gastric-cancer","display_name":"HER2-positive gastric cancer","score":0.9869999885559082},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":1.0},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7480000257492065},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.7310000061988831},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.597000002861023},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.656000018119812},{"id":"https://openalex.org/keywords/autophagy","display_name":"autophagy","score":0.9269999861717224},{"id":"https://openalex.org/keywords/caspase-8","display_name":"caspase-8","score":0.8019999861717224},{"id":"https://openalex.org/keywords/caspase-9","display_name":"caspase-9","score":0.9890000224113464},{"id":"https://openalex.org/keywords/beclin-1","display_name":"Beclin-1","score":0.699999988079071},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.5320000052452087},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.7590000033378601},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":0.8740000128746033},{"id":"https://openalex.org/keywords/mmp-2","display_name":"MMP-2","score":0.7210000157356262},{"id":"https://openalex.org/keywords/icam-1","display_name":"ICAM-1","score":0.968999981880188},{"id":"https://openalex.org/keywords/anti-her2-monoclonal-antibody","display_name":"anti-HER2 monoclonal antibody","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.9118000268936157},{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.823199987411499},{"id":"https://openalex.org/C203522944","wikidata":"https://www.wikidata.org/wiki/Q288322","display_name":"Autophagy","level":3,"score":0.6816999912261963},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6366000175476074},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6225000023841858},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.6116999983787537},{"id":"https://openalex.org/C88634738","wikidata":"https://www.wikidata.org/wiki/Q24769543","display_name":"Annexin","level":3,"score":0.5802000164985657},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.5619999766349792},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5321999788284302},{"id":"https://openalex.org/C2781000418","wikidata":"https://www.wikidata.org/wiki/Q18034312","display_name":"ATG5","level":4,"score":0.49559998512268066},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43939998745918274},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4235000014305115},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4108999967575073},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.40540000796318054},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.39340001344680786},{"id":"https://openalex.org/C2775934118","wikidata":"https://www.wikidata.org/wiki/Q424169","display_name":"Propidium iodide","level":4,"score":0.34709998965263367},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.3393999934196472},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3221000134944916},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.31679999828338623},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3158999979496002},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2985999882221222},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.290800005197525},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.2833000123500824},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27320000529289246},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2703999876976013},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.2702000141143799},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2558000087738037}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0679","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0679","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0679","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A769.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0679","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0679","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0679","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A769.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225335218.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362671109","https://openalex.org/W7225302814","https://openalex.org/W3147371792","https://openalex.org/W3193635119","https://openalex.org/W1964230131","https://openalex.org/W2330582602","https://openalex.org/W2142416576","https://openalex.org/W2127464356","https://openalex.org/W2122983196","https://openalex.org/W2439644539"],"abstract_inverted_index":{"Background":[0],"HER2":[1,370],"overexpression":[2],"drives":[3],"oncogenic":[4],"signaling":[5],"in":[6,64,82,182,250,316,330,372],"a":[7,41,57,351,361],"subset":[8],"of":[9,44,54,56,167,243,320,343],"gastric":[10,84,89,332,373],"cancers,":[11],"and":[12,63,71,79,114,123,137,145,157,163,172,206,225,229,239,260,279,296,341,348],"trastuzumab":[13,70,104,205,312,323],"combined":[14,102],"with":[15,66,73,96,103,204,208,211,220,233,311,322],"chemotherapy":[16],"remains":[17],"the":[18,31,51,244,369],"standard":[19],"first-line":[20],"treatment":[21],"for":[22,33,109,213,364],"HER2-positive":[23,83,331],"disease.":[24],"However,":[25],"clinical":[26],"outcomes":[27],"remain":[28],"poor,":[29],"underscoring":[30],"need":[32],"novel":[34,58],"therapeutic":[35],"strategies.":[36],"4-Thiazolidinone-based":[37],"hybrid":[38],"molecules":[39],"represent":[40],"promising":[42,362],"class":[43],"multi-targeting":[45],"anticancer":[46,328],"agents.":[47],"Here,":[48],"we":[49],"investigated":[50],"molecular":[52],"mechanism":[53],"action":[55],"pyrazoline-thiazolidinone":[59],"derivative,":[60],"Les-4367,":[61,198],"alone":[62,100],"combination":[65,252,319,365],"anti-HER2":[67],"monoclonal":[68],"antibodies":[69,190],"pertuzumab,":[72,209],"focus":[74],"on":[75],"apoptosis,":[76],"autophagy":[77,146,339],"suppression,":[78,340],"immunomodulatory":[80],"effects":[81],"cancer":[85,90,333],"cells.Methods":[86],"Human":[87],"AGS":[88,183],"cells":[91,184],"(HER2":[92],"+)":[93],"were":[94,117,140,159,174,267,302],"treated":[95],"Les-4367":[97,178,321,359],"(1\u20135":[98],"\u03bcM)":[99],"or":[101,105,324],"pertuzumab":[106,221,325],"(10":[107],"\u03bcg/mL)":[108],"24":[110],"h.":[111],"Cell":[112],"viability":[113,121],"DNA":[115],"biosynthesis":[116],"assessed":[118],"by":[119,130,142,147,161,176,255],"fixable":[120],"staining":[122],"[3H]thymidine":[124],"incorporation":[125],"assay.":[126],"Apoptosis":[127],"was":[128,248],"quantified":[129],"Annexin":[131],"V-FITC/propidium":[132],"iodide":[133],"flow":[134],"cytometry.":[135],"Caspase-8":[136],"caspase-9":[138,240],"activity":[139,235,329],"measured":[141],"FAM-FLICA":[143],"assay,":[144],"ICT":[148],"Autophagy":[149,152,247],"Assay":[150],"Red.":[151],"markers":[153,266,346],"Beclin-1,":[154,257],"LC3A,":[155,258],"LC3B,":[156,259],"ATG5":[158,261],"evaluated":[160],"ELISA":[162],"Western":[164],"blot.":[165],"Concentrations":[166],"MMP-2,":[168],"ICAM-1,":[169,349],"IL-6,":[170],"IL-8,":[171],"IL-10":[173,306],"determined":[175],"ELISA.Results":[177],"displayed":[179],"potent":[180],"cytotoxicity":[181],"(IC":[185],"50":[186],"1.5":[187],"\u03bcM).":[188],"Both":[189],"markedly":[191],"enhanced":[192],"its":[193],"efficacy:":[194],"at":[195],"1":[196],"\u03bcM":[197],"dead":[199],"cell":[200,245],"fractions":[201],"reached":[202],"67.9%":[203],"83.0%":[207],"compared":[210],"44.8%":[212],"monotherapy.":[214],"Combination":[215],"regimens":[216],"amplified":[217],"apoptosis":[218],"(69.8%":[219],"vs.":[222],"56.2%":[223],"alone)":[224],"activated":[226],"both":[227],"extrinsic":[228],"intrinsic":[230],"apoptotic":[231,336],"pathways,":[232],"caspase-8":[234],"rising":[236],"to":[237,241,273,283,308],"83.7\u201384.6%":[238],"87.3\u201387.6%":[242],"population.":[246],"suppressed":[249],"all":[251],"groups,":[253],"confirmed":[254],"reduced":[256],"levels.":[262],"Key":[263],"immune":[264,344],"evasion":[265,345],"downregulated:":[268],"MMP-2":[269,347],"decreased":[270],"from":[271,281],"700":[272],"225.6":[274],"ng/mL":[275],"(Les-4367":[276,286],"+":[277,287],"pertuzumab)":[278],"ICAM-1":[280],"481":[282],"358.5":[284],"pg/mL":[285,310,315],"trastuzumab).":[288],"Pro-inflammatory":[289],"cytokines":[290],"IL-6":[291],"(17.99":[292],"\u2192":[293,299],"12.2":[294],"pg/mL)":[295,301],"IL-8":[297],"(246.3":[298],"193.0":[300],"reduced,":[303],"while":[304],"anti-inflammatory":[305,353],"increased":[307],"49.1":[309],"versus":[313],"34.0":[314],"controls.Conclusions":[317],"The":[318],"exerts":[326],"synergistic":[327],"through":[334],"dual":[335],"pathway":[337,371],"activation,":[338],"downregulation":[342],"alongside":[350],"favourable":[352],"cytokine":[354],"shift.":[355],"These":[356],"findings":[357],"support":[358],"as":[360],"candidate":[363],"immunotherapy":[366],"strategies":[367],"targeting":[368],"cancer.":[374]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-11-06T00:00:00"}